Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

A Simple In Vitro Gut Model for Studying the Interaction between Escherichia coli and the Intestinal Commensal Microbiota in Cecal Mucus.

Mokszycki ME, Leatham-Jensen M, Steffensen JL, Zhang Y, Krogfelt KA, Caldwell ME, Conway T, Cohen PS.

Appl Environ Microbiol. 2018 Nov 30;84(24). pii: e02166-18. doi: 10.1128/AEM.02166-18. Print 2018 Dec 15.

2.

Uropathogenic Escherichia coli Metabolite-Dependent Quiescence and Persistence May Explain Antibiotic Tolerance during Urinary Tract Infection.

Leatham-Jensen MP, Mokszycki ME, Rowley DC, Deering R, Camberg JL, Sokurenko EV, Tchesnokova VL, Frimodt-Møller J, Krogfelt KA, Leth Nielsen K, Frimodt-Møller N, Sun G, Cohen PS.

mSphere. 2016 Jan 20;1(1). pii: e00055-15. doi: 10.1128/mSphere.00055-15. eCollection 2016 Jan-Feb.

3.

Escherichia coli EDL933 requires gluconeogenic nutrients to successfully colonize the intestines of streptomycin-treated mice precolonized with E. coli Nissle 1917.

Schinner SA, Mokszycki ME, Adediran J, Leatham-Jensen M, Conway T, Cohen PS.

Infect Immun. 2015 May;83(5):1983-91. doi: 10.1128/IAI.02943-14. Epub 2015 Mar 2.

4.

An Escherichia coli Nissle 1917 missense mutant colonizes the streptomycin-treated mouse intestine better than the wild type but is not a better probiotic.

Adediran J, Leatham-Jensen MP, Mokszycki ME, Frimodt-Møller J, Krogfelt KA, Kazmierczak K, Kenney LJ, Conway T, Cohen PS.

Infect Immun. 2014 Feb;82(2):670-82. doi: 10.1128/IAI.01149-13. Epub 2013 Nov 25.

5.

The streptomycin-treated mouse intestine selects Escherichia coli envZ missense mutants that interact with dense and diverse intestinal microbiota.

Leatham-Jensen MP, Frimodt-Møller J, Adediran J, Mokszycki ME, Banner ME, Caughron JE, Krogfelt KA, Conway T, Cohen PS.

Infect Immun. 2012 May;80(5):1716-27. doi: 10.1128/IAI.06193-11. Epub 2012 Mar 5.

Supplemental Content

Loading ...
Support Center